The Lancet Diabetes & Endocrinology Volume 12 Issue 1 to 3

The Lancet Diabetes & Endocrinology is a prestigious journal that serves as a leading platform for key opinion leaders in medicine, government, and health systems to influence clinical practice, drive global policy, and foster positive change worldwide. The journal is recognized as a global authority in diabetes and endocrinology, providing essential original research and expert reviews that offer a clear and independent perspective on the clinical advancements and groundbreaking research shaping these fields on a global scale.

The Lancet Diabetes & Endocrinology publishes papers that encompass the wide range of clinical research in the field of diabetes and endocrinology. It covers diverse topics including diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, pediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders. The journal showcases the latest research findings, clinical trials, and practice-changing advancements in these areas, contributing to the collective knowledge and understanding of these complex and evolving fields.

By providing a platform for high-quality research and delivering expert reviews and commentary, The Lancet Diabetes & Endocrinology plays a vital role in shaping clinical practice, informing global policy, and promoting positive changes in the field of diabetes and endocrinology. The journal serves as a trusted source of information for healthcare professionals, researchers, and policymakers, facilitating the dissemination of important research findings and stimulating critical discussions to drive advancements in patient care and outcomes.

Volume 12, Issue 1: Pages 1-82, e1-e11 (January 2024)

Volume 12, Issue 2: Pages 83-148, e12 (February 2024)

Volume 12, Issue 3: Pages 149-214, e13-e16 (March 2024)